DDIT4L (DNA damage inducible transcript 4 like) is a negative mTOR regulator that inhibits cell growth by suppressing mTORC1 signaling upstream of the TSC1-TSC2 complex 1. DDIT4L functions primarily through mTOR pathway inhibition, with downstream effects on cellular metabolism and stress responses. In immune cells, DDIT4L overexpression suppresses mitochondrial activity and blunts LPS-induced cytokine responses, suggesting a role in attenuating innate immunity during early development 2. In pancreatic β-cells, DDIT4L is induced by oxidative stress through Nrf2 and p53 transcription factors and promotes β-cell dysfunction and apoptosis via mTORC1 inhibition; DDIT4L knockout improves glucose tolerance under high-fat diet conditions 3. In cardiac tissue, DDIT4L promotes autophagy and inhibits pathological hypertrophy through mTORC1 suppression while activating mTORC2 1. DDIT4L also functions in fibrosis regulation, where the lncRNA H19X represses DDIT4L expression, leading to increased collagen production 4. Clinically, DDIT4L serves as a shared diagnostic biomarker for periodontitis and multiple sclerosis 5, and altered circulating DDIT4L in extracellular vesicles correlates with cardiac transplant ischemia-reperfusion injury 6. Dysregulated DDIT4L expression has been implicated in BPA-induced pancreatic injury 7 and brucellosis disease progression 8.